Analysts expect Zentalis Pharmaceuticals, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 26.90 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.22 M | 1.75 M | 2.52 M | 10.63 M | 14.41 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.08 M | 1.46 M | 2.07 M | 10.00 M | 12.69 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.15 M | 1.60 M | 2.30 M | 10.31 M | 13.55 M |
Analysts expect Zentalis Pharmaceuticals, Inc. to report earnings per share of -0.61 for Q3 26, against a range of -0.64 to -0.58. The most recent reported quarter, Q2 26, came in at -0.59, a 13.5% miss against the -0.52 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.56 | -0.67 | -0.67 | -0.37 | -0.37 | -0.50 | -0.50 | -0.59 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.81 | -0.61 | -0.63 | -0.55 | -0.52 | -0.40 | -0.48 | -0.50 | -0.58 | -0.51 | -0.50 | -0.49 | -0.48 | -0.48 | -0.41 | -0.40 | ||||||||||
| Low Estimate | -0.95 | -0.73 | -0.73 | -0.61 | -0.60 | -0.44 | -0.52 | -0.54 | -0.64 | -0.59 | -0.60 | -0.59 | -0.56 | -0.52 | -0.43 | -0.48 | ||||||||||
| Consensus Estimate | -0.88 | -0.67 | -0.68 | -0.58 | -0.56 | -0.42 | -0.50 | -0.52 | -0.61 | -0.55 | -0.55 | -0.54 | -0.52 | -0.50 | -0.42 | -0.44 |
Pull Wall Street consensus for Zentalis Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ZNTL&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ZNTL", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ZNTL&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();